Liraglutide 3.0 mg Reduces Body Weight and Improves Health-Related Quality of Life (HRQoL) in Overweight or Obese Adults without Diabetes: The SCALE Obesity and Prediabetes Randomized, Double-Blind, Placebo-Controlled, 56-Week Trial
- Resource Type
- Source
- Canadian Journal of Diabetes. 39:S36
- Subject
Health related quality of life medicine.medical_specialty Pediatrics Liraglutide business.industry Endocrinology, Diabetes and Metabolism General Medicine Overweight Placebo medicine.disease Obesity Double blind Endocrinology Diabetes mellitus Internal Medicine medicine Physical therapy Prediabetes medicine.symptom business medicine.drug - Language
- ISSN
- 1499-2671